Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 774

1.

Chemoprevention: A new concept for cancer prevention in primary care

Emery JD, Nguyen P, Minshall J, Cummings KL, Walker J.

Aust J Gen Pract. 2018 Dec;47(12):825-828.

PMID:
31212398
2.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.

Jenkins MA, Win AK, Dowty JG, MacInnis RJ, Makalic E, Schmidt DF, Dite GS, Kapuscinski M, Clendenning M, Rosty C, Winship IM, Emery JD, Saya S, Macrae FA, Ahnen DJ, Duggan D, Figueiredo JC, Lindor NM, Haile RW, Potter JD, Cotterchio M, Gallinger S, Newcomb PA, Buchanan DD, Casey G, Hopper JL.

Fam Cancer. 2019 Jun 17. doi: 10.1007/s10689-019-00136-6. [Epub ahead of print]

PMID:
31209717
3.

Evaluating diagnostic strategies for early detection of cancer: the CanTest framework.

Walter FM, Thompson MJ, Wellwood I, Abel GA, Hamilton W, Johnson M, Lyratzopoulos G, Messenger MP, Neal RD, Rubin G, Singh H, Spencer A, Sutton S, Vedsted P, Emery JD.

BMC Cancer. 2019 Jun 14;19(1):586. doi: 10.1186/s12885-019-5746-6.

4.

Lung cancer.

Neal RD, Sun F, Emery JD, Callister ME.

BMJ. 2019 Jun 3;365:l1725. doi: 10.1136/bmj.l1725. No abstract available.

PMID:
31160279
5.

Knowledge and Education as Barriers and Facilitators to Nicotine Replacement Therapy Use for Smoking Cessation in Pregnancy: A Qualitative Study with Health Care Professionals.

Thomson R, McDaid L, Emery J, Naughton F, Cooper S, Dyas J, Coleman T.

Int J Environ Res Public Health. 2019 May 22;16(10). pii: E1814. doi: 10.3390/ijerph16101814.

6.

Understanding implementation and usefulness of electronic clinical decision support (eCDS) for melanoma in English primary care: a qualitative investigation.

Pannebakker MM, Mills K, Johnson M, Emery JD, Walter FM.

BJGP Open. 2019 Mar 20;3(1):bjgpopen18X101635. doi: 10.3399/bjgpopen18X101635. eCollection 2019 Apr.

7.

Research evidence supports cancer policymaking but is insufficient for change: Findings of key informant interviews from five countries.

Bergin RJ, Emery J, Bollard R, White V.

Health Policy. 2019 Jun;123(6):572-581. doi: 10.1016/j.healthpol.2019.04.003. Epub 2019 Apr 13.

PMID:
31005343
8.

Dermoscopy use in UK primary care: a survey of GPs with a special interest in dermatology.

Jones OT, Jurascheck LC, Utukuri M, Pannebakker MM, Emery J, Walter FM.

J Eur Acad Dermatol Venereol. 2019 Apr 12. doi: 10.1111/jdv.15614. [Epub ahead of print]

PMID:
30977937
9.

Gathering data for decisions: best practice use of primary care electronic records for research.

Canaway R, Boyle DI, Manski-Nankervis JE, Bell J, Hocking JS, Clarke K, Clark M, Gunn JM, Emery JD.

Med J Aust. 2019 Apr;210 Suppl 6:S12-S16. doi: 10.5694/mja2.50026.

10.

A randomised phase II trial to examine feasibility of standardised, early palliative (STEP) care for patients with advanced cancer and their families [ACTRN12617000534381]: a research protocol.

Philip J, Collins A, Le B, Sundararajan V, Brand C, Hanson S, Emery J, Hudson P, Mileshkin L, Ganiatsas S.

Pilot Feasibility Stud. 2019 Mar 14;5:44. doi: 10.1186/s40814-019-0424-7. eCollection 2019.

11.

The unexpected surface of asteroid (101955) Bennu.

Lauretta DS, DellaGiustina DN, Bennett CA, Golish DR, Becker KJ, Balram-Knutson SS, Barnouin OS, Becker TL, Bottke WF, Boynton WV, Campins H, Clark BE, Connolly HC Jr, Drouet d'Aubigny CY, Dworkin JP, Emery JP, Enos HL, Hamilton VE, Hergenrother CW, Howell ES, Izawa MRM, Kaplan HH, Nolan MC, Rizk B, Roper HL, Scheeres DJ, Smith PH, Walsh KJ, Wolner CWV; OSIRIS-REx Team.

Nature. 2019 Apr;568(7750):55-60. doi: 10.1038/s41586-019-1033-6. Epub 2019 Mar 19.

PMID:
30890786
12.

Do cognitive heuristics underpin symptom appraisal for symptoms of cancer?: A secondary qualitative analysis across seven cancers.

Kummer S, Walter FM, Chilcot J, Emery J, Sutton S, Scott SE.

Psychooncology. 2019 May;28(5):1041-1047. doi: 10.1002/pon.5049. Epub 2019 Mar 18.

PMID:
30828881
13.

Spotting the old foe-revisiting the case definition for TB.

Houben RMGJ, Esmail H, Emery JC, Joslyn LR, McQuaid CF, Menzies NA, Sanz J, Shrestha S, White RG, Yang C, Cobelens F.

Lancet Respir Med. 2019 Mar;7(3):199-201. doi: 10.1016/S2213-2600(19)30038-4. No abstract available.

PMID:
30823971
14.

The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Lo LL, Collins IM, Bressel M, Butow P, Emery J, Keogh L, Weideman P, Steel E, Hopper JL, Trainer AH, Mann GB, Bickerstaffe A, Antoniou AC, Cuzick J, Phillips KA.

JMIR Form Res. 2018 Nov 7;2(2):e24. doi: 10.2196/formative.9935.

15.

The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer.

Emery JD, Murray SR, Walter FM, Martin A, Goodall S, Mazza D, Habgood E, Kutzer Y, Barnes DJ, Murchie P.

Thorax. 2019 Apr;74(4):362-370. doi: 10.1136/thoraxjnl-2018-212506. Epub 2019 Jan 10.

16.

Development of an intervention to expedite cancer diagnosis through primary care: a protocol.

Stanciu MA, Law RJ, Nafees S, Hendry M, Yeo ST, Hiscock J, Lewis R, Edwards RT, Williams NH, Brain K, Brocklehurst P, Carson-Stevens A, Dolwani S, Emery J, Hamilton W, Hoare Z, Lyratzopoulos G, Rubin G, Smits S, Vedsted P, Walter F, Wilkinson C, Neal RD; WICKED Team on behalf of.

BJGP Open. 2018 Sep 5;2(3):bjgpopen18X101595. doi: 10.3399/bjgpopen18X101595. eCollection 2018 Oct.

17.

Victorian Comprehensive Cancer Centre lung cancer clinical audit: collecting the UK National Lung Cancer Audit data from hospitals in Australia.

Mileshkin L, Dunn C, Cross H, Duffy M, Shaw M, Antippa P, Mitchell P, Akhurst T, Conron M, Moore M, Philip J, Bartlett J, Emery J, Zambello B.

Intern Med J. 2018 Dec 4. doi: 10.1111/imj.14183. [Epub ahead of print]

PMID:
30515932
18.

A pilot study comparing peer supported web-based CBT to self-managed web CBT for primary care veterans with PTSD and hazardous alcohol use.

Possemato K, Johnson EM, Emery JB, Wade M, Acosta MC, Marsch LA, Rosenblum A, Maisto SA.

Psychiatr Rehabil J. 2018 Nov 29. doi: 10.1037/prj0000334. [Epub ahead of print]

PMID:
30489140
19.

Consumer and clinician perspectives on personalising breast cancer prevention information.

Keogh LA, Steel E, Weideman P, Butow P, Collins IM, Emery JD, Mann GB, Bickerstaffe A, Trainer AH, Hopper LJ, Phillips KA.

Breast. 2019 Feb;43:39-47. doi: 10.1016/j.breast.2018.11.002. Epub 2018 Nov 7.

PMID:
30445378
20.

Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.

Vázquez-Rosa E, Watson MR, Sahn JJ, Hodges TR, Schroeder RE, Cintrón-Pérez CJ, Shin MK, Yin TC, Emery JL, Martin SF, Liebl DJ, Pieper AA.

ACS Chem Neurosci. 2019 Mar 20;10(3):1595-1602. doi: 10.1021/acschemneuro.8b00543. Epub 2018 Dec 3.

PMID:
30421909
21.

Revised Australian national guidelines for colorectal cancer screening: family history.

Jenkins MA, Ait Ouakrim D, Boussioutas A, Hopper JL, Ee HC, Emery JD, Macrae FA, Chetcuti A, Wuellner L, St John DJB.

Med J Aust. 2018 Nov 19;209(10):455-460. Epub 2018 Oct 29.

PMID:
30359558
22.

The influence of health literacy on the timely diagnosis of symptomatic cancer: A systematic review.

Humphrys E, Burt J, Rubin G, Emery JD, Walter FM.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12920. doi: 10.1111/ecc.12920. Epub 2018 Oct 16.

23.

Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia.

Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Greuter MJE, Coupé VMH, Canfell K.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1450-1461. doi: 10.1158/1055-9965.EPI-18-0128. Epub 2018 Sep 6.

PMID:
30190276
24.

The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments.

Coxon D, Campbell C, Walter FM, Scott SE, Neal RD, Vedsted P, Emery J, Rubin G, Hamilton W, Weller D.

BMC Health Serv Res. 2018 Sep 3;18(1):677. doi: 10.1186/s12913-018-3476-0.

25.

The Role of Primary Care Physicians in Childhood Cancer Survivorship Care: Multiperspective Interviews.

Signorelli C, Wakefield CE, Fardell JE, Foreman T, Johnston KA, Emery J, Thornton-Benko E, Girgis A, Lie HC, Cohn RJ; Anzchog Survivorship Study Group.

Oncologist. 2019 May;24(5):710-719. doi: 10.1634/theoncologist.2018-0103. Epub 2018 Aug 31.

PMID:
30171066
26.

Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.

Dillon M, Flander L, Buchanan DD, Macrae FA, Emery JD, Winship IM, Boussioutas A, Giles GG, Hopper JL, Jenkins MA, Ait Ouakrim D.

PLoS Med. 2018 Aug 16;15(8):e1002630. doi: 10.1371/journal.pmed.1002630. eCollection 2018 Aug.

27.

The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.

Walker JG, Macrae F, Winship I, Oberoi J, Saya S, Milton S, Bickerstaffe A, Dowty JG, De Abreu Lourenço R, Clark M, Galloway L, Fishman G, Walter FM, Flander L, Chondros P, Ait Ouakrim D, Pirotta M, Trevena L, Jenkins MA, Emery JD.

Trials. 2018 Jul 25;19(1):397. doi: 10.1186/s13063-018-2764-7.

28.
29.

Rural-Urban Disparities in Time to Diagnosis and Treatment for Colorectal and Breast Cancer.

Bergin RJ, Emery J, Bollard RC, Falborg AZ, Jensen H, Weller D, Menon U, Vedsted P, Thomas RJ, Whitfield K, White V.

Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1036-1046. doi: 10.1158/1055-9965.EPI-18-0210. Epub 2018 Jul 9.

PMID:
29987098
30.

Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: An Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma.

Wilson ECF, Usher-Smith JA, Emery J, Corrie PG, Walter FM.

Value Health. 2018 Jun;21(6):669-676. doi: 10.1016/j.jval.2017.10.009. Epub 2017 Dec 8.

31.

A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom.

Wilson ECF, Usher-Smith JA, Emery J, Corrie P, Walter FM.

Value Health. 2018 Jun;21(6):658-668. doi: 10.1016/j.jval.2017.11.009. Epub 2018 Apr 11.

32.

Uptake of Tailored Text Message Smoking Cessation Support in Pregnancy When Advertised on the Internet (MiQuit): Observational Study.

Emery JL, Coleman T, Sutton S, Cooper S, Leonardi-Bee J, Jones M, Naughton F.

J Med Internet Res. 2018 Apr 19;20(4):e146. doi: 10.2196/jmir.8525.

33.

Resolving the Chemically Discrete Structure of Synthetic Borophene Polymorphs.

Campbell GP, Mannix AJ, Emery JD, Lee TL, Guisinger NP, Hersam MC, Bedzyk MJ.

Nano Lett. 2018 May 9;18(5):2816-2821. doi: 10.1021/acs.nanolett.7b05178. Epub 2018 Apr 23.

PMID:
29653052
34.

The CRISP-Q study: Communicating the risks and benefits of colorectal cancer screening

Kim GY, Walker J, Bickerstaffe A, Hewabandu N, Pirotta M, Flander L, Jenkins M, Emery J.

Aust J Gen Pract. 2018 Mar;47(3):139-145.

35.

Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study.

Nair-Shalliker V, Bang A, Weber M, Goldsbury DE, Caruana M, Emery J, Banks E, Canfell K, O'Connell DL, Smith DP.

Sci Rep. 2018 Mar 9;8(1):4261. doi: 10.1038/s41598-018-22589-y.

36.

Knowing and telling: how African-Australians living with chronic hepatitis B understand hepatocellular carcinoma risk and surveillance.

Allard N, Emery J, Cowie B, Furler J.

Aust J Prim Health. 2018 May;24(2):141-148. doi: 10.1071/PY17099.

PMID:
29481766
37.

Find Cancer Early: Evaluation of a Community Education Campaign to Increase Awareness of Cancer Signs and Symptoms in People in Regional Western Australians.

Croager EJ, Gray V, Pratt IS, Slevin T, Pettigrew S, Holman CD, Bulsara M, Emery J.

Front Public Health. 2018 Feb 8;6:22. doi: 10.3389/fpubh.2018.00022. eCollection 2018. Review.

38.

The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia.

Emery JD, Gray V, Walter FM, Cheetham S, Croager EJ, Slevin T, Saunders C, Threlfall T, Auret K, Nowak AK, Geelhoed E, Bulsara M, Holman CDJ.

Br J Cancer. 2018 Mar 20;118(6):e8. doi: 10.1038/bjc.2017.457. Epub 2018 Feb 15.

39.

Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.

Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Sarfati D, Greuter MJE, Coupé VMH, Canfell K.

Int J Cancer. 2018 Jul 15;143(2):269-282. doi: 10.1002/ijc.31314. Epub 2018 Mar 8.

PMID:
29441568
40.

Reimagining the diagnostic pathway for gastrointestinal cancer.

Rubin G, Walter F, Emery J, de Wit N.

Nat Rev Gastroenterol Hepatol. 2018 Mar;15(3):181-188. doi: 10.1038/nrgastro.2018.1. Epub 2018 Feb 7. Review.

PMID:
29410534
41.

Mechanistic understanding of tungsten oxide in-plane nanostructure growth via sequential infiltration synthesis.

Kim JJ, Suh HS, Zhou C, Mane AU, Lee B, Kim S, Emery JD, Elam JW, Nealey PF, Fenter P, Fister TT.

Nanoscale. 2018 Feb 15;10(7):3469-3479. doi: 10.1039/c7nr07642h.

PMID:
29404547
42.

External validation of risk prediction models for incident colorectal cancer using UK Biobank.

Usher-Smith JA, Harshfield A, Saunders CL, Sharp SJ, Emery J, Walter FM, Muir K, Griffin SJ.

Br J Cancer. 2018 Mar 6;118(5):750-759. doi: 10.1038/bjc.2017.463. Epub 2018 Jan 30.

43.

Measuring Dipole Inversion in Self-Assembled Nano-Dielectric Molecular Layers.

Zeng L, Turrisi R, Fu B, Emery JD, Walker AR, Ratner MA, Hersam MC, Facchetti AF, Marks TJ, Bedzyk MJ.

ACS Appl Mater Interfaces. 2018 Feb 21;10(7):6484-6490. doi: 10.1021/acsami.7b16160. Epub 2018 Feb 12.

PMID:
29378110
44.

TLR2 agonism reverses chemotherapy-induced neutropenia in Macaca fascicularis.

Laping NJ, DeMartino MP, Cottom JE, Axten JM, Emery JG, Guss JH, Burman M, Foley JJ, Cheung M, Oliff A, Kumar S.

Blood Adv. 2017 Dec 8;1(26):2553-2562. doi: 10.1182/bloodadvances.2017010611. eCollection 2017 Dec 12.

45.

Fragile X population carrier screening.

Metcalfe SA, Delatycki MB, Cohen J, Archibald AD, Emery JD.

Genet Med. 2018 Sep;20(9):1091-1092. doi: 10.1038/gim.2017.209. No abstract available.

PMID:
29215647
46.

Lung cancer in Asian women and health system implications for Australia.

Emery JD, Mitchell PL.

Lancet Oncol. 2017 Dec;18(12):1570-1571. doi: 10.1016/S1470-2045(17)30853-7. No abstract available.

PMID:
29208428
47.

Effect of a vitamin and mineral supplementation on glycemic status: Results from a community-based program.

Kimball SM, Emery JCH, Lewanczuk RZ.

J Clin Transl Endocrinol. 2017 Nov 7;10:28-35. doi: 10.1016/j.jcte.2017.11.002. eCollection 2017 Dec.

48.

Protocol for the melatools skin self-monitoring trial: a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma.

Mills K, Emery J, Lantaff R, Radford M, Pannebakker M, Hall P, Burrows N, Williams K, Saunders CL, Murchie P, Walter FM.

BMJ Open. 2017 Nov 28;7(11):e017934. doi: 10.1136/bmjopen-2017-017934.

49.

Crossing the lines between epilepsy syndromes: a myoclonic epilepsy variant with prominent eyelid myoclonia and atonic components.

Dragoumi P, Emery J, Chivers F, Brady M, Desurkar A, Cross JH, Das KB.

Epileptic Disord. 2018 Feb 1;20(1):35-41. doi: 10.1684/epd.2017.0937.

50.

Reducing barriers to consulting a General Practitioner in patients at increased risk of lung cancer: a qualitative evaluation of the CHEST Australia intervention.

Murray SR, Kutzer Y, Habgood E, Murchie P, Walter FM, Mazza D, Shahid S, Emery JD.

Fam Pract. 2017 Nov 16;34(6):740-746. doi: 10.1093/fampra/cmx057.

PMID:
29155969

Supplemental Content

Support Center